CDSCO permits drug manufacturers to alter the labels pursuant to implementation of GST
The Central Drugs Standard Control Organization (“CDSCO”) has clarified through a notification on 10th July, 2017 that it has no objection with respect toalteration of labels (stickering) by the drug manufacturers pursuant to the implementation of GST.
Rule 104A of the Drugs and Cosmetics Rules, 1945 (“Rules”) prohibits drug manufacturers to alter inscriptions on containers, labels or wrappers of drugs. However, the prohibition is not applicable at the direction or permission of the licensing authority.
With the coming into force of the GST regime, manufacturers across the country, including drug manufacturers are required to alter the prices of their products. Therefore, the CDSCO has clarified that subject to the provisions of the Legal Metrology Act , 2009 and allied rules, it has no objection for alteration of label (stickering) by the drug manufacturers, if its required for implementation of GST.